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Summary
The purpose of this study was to evaluate the use
of a compression garment as DOMS prevention.
This was accomplished by provoking a DOMS
in 15 athletes, running on a treadmill at 73% of
their maximal aerobic velocity, during 40 minutes
with a 10% negative slope; wearing the compres-
sion garments on one thigh, protected thigh (PT),
and not in the contralateral thigh, control thigh
(CT).
A clinical and MRI diagnosis of DOMS was per-
formed. Biopsies in both vastus lateralis were
done, and the amount and severity of the DOMS
was estimated by measuring intracellular albumin,
and lymphocytes CD3+ and neutrophils intra/inter-
fibrilar infiltrates, 48h after the induced damaging
exercise.
There was less total injury in the PT than in the
CT, a 26.7% average. These data indicate that this
compression garment is an effective method to re-
duce the histological injury in DOMS.
KEY WORDS: albumin, biopsy, eccentric, inflammato-
ry cells, muscle.
Introduction
Delayed onset muscle soreness (DOMS)1 is the dis-
comfort and pain while the muscle contracts, it ap-
pears after doing unusual exercise, and normally al-
though not exclusively, related to eccentric muscular
work2,3. Muscle soreness is accompanied by a feeling
of stiffness as a result of muscle oedema4, as well as
a loss of strength and range of movement (ROM)5,6.
The signs and symptoms begin between 6-12 h after
exercise, increase progressively until reaching a peak
pain between 48-72 h, and reduce until they disap-
pear between 5-7 days later2,7,8. DOMS is also ac-
companied by biochemical alterations like an in-
crease of CPK in the blood9. In some studies it is
classified as a muscle injury grade 110, although its
clinical evolution is different1,11. In fact, it has been
used as an experimental model to study the muscle
injury12.
Compression garments as a therapeutic or preventa-
tive measure, are normally used in different scopes of
medicine (vascular pathology, plastic surgery, in
sports medicine). Multiple articles have appraised the
effect of the compressive garments on muscle func-
tion12-23 recovery post exercise24-29, motor control30,
thermoregulation31, warming up17 and ROM17,32. Com-
pression garments for DOMS recovery have also been
studied by applying compression measures after the
bout of exercise27,33-36, however, the compression
garments assessed are made of distinct materials and
they differ in composition, architecture or degree of
compression, making difficult to compare results.
Moreover, compression garments have not been stud-
ied as a preventative strategy during provocation.
Signs of histological muscle damage in DOMS are
myofibrillar structure disruptions and myofibre necro-
sis and inflammation37. Sarcolemmal membrane injury
allows extracellular proteins like albumin to be detect-
ed intracellular, this is a sign of membrane injury38,39.
The inflammatory reaction within myofibres is a sign of
segmental myofibre degradation and necrosis,  neu-
trophils (MPO) and lymphocytes CD3+ (CD3+) reflect
the amount and intensity of cellular damage37,40.
Thus, the aim of this study is to evaluate if there is a
protective effect of compression against DOMS; more
specifically, the protective effect of this compression
garments against DOMS. For this purpose we will
evaluate the amount of damaged fibbers and the
severity of this damage by measuring intracellular al-
bumin, lymphocytes CD3+ (CD3+) and neutrophils
Original article
©
 C
IC
 Ed
izi
on
i I
nt
er
n
zio
na
li
(MPO) intra/interfibrilar infiltrates, after the induced
damaging exercise.
Methods
Experimental approach to the problem
An experimental, prospective study, involving healthy
athletes with no clinical history of interest, and who regu-
larly did physical activity, was designed. Each individual
served as own control, since one thigh wore the com-
pression garment, protected thigh (PT), while the other
remained unprotected, control thigh (CT), Figure 1.
Subjects
Adult male amateur soccer players from two different lo-
cal clubs, older than 18 years, with a regular training ac-
tivity from 4-12 hours per week during at least 3 months,
were considered to take part in the study. Three weeks
before the study they were instructed to eat normally,
and to avoid: unusual physical activity, alcohol, and any
toxic substances until the end of the study. Neither did
they have any medical or pharmacological (NSAID,
analgesic) treatment, or any physical measurement that
could alter the result of the injury (cryotherapy, warm
baths, massage, electrotherapy, etc.).
Previous to the inclusion, the subjects were informed
about the protocol and its objectives and gave their
consent to take part in the study. The project was previ-
ously assessed and approved by the ethics committee
of the Consell Català de l’Esport (0099S/ 4882/2010).
Sixteen individuals were initially included in the study;
nevertheless, the final sample was 15 because one of
the subjects could not complete the study. The main
physical and physiological baseline characteristics of
the subjects evaluated are shown in Table 1. Addition-
ally, the distribution of the subjects leg dominance, to-
gether with randomization for the compression, are
shown in Table 2. Athletes were allocated in the right
or left thigh compression group following a randomiza-
tion process by taking random numbers from a com-
puter program, a summary of the protocol is shown in
Figure 3A, and the flow Diagram Figure 3B. 
Procedures
Compression tights: the compression tights used in
the study (Colibri®, Puntiblond, Spain) are made of a
combination of a compression fabric (polyamide 57%
and elastomer 43%), with inner reinforcements over
the quadriceps and hamstrings, Figure 2 A and B.
The tights composition and its 3D structure allow it to
control the elasticity at 360°, Figure 2-C41. The level
of compression was not measured, all subjects used
the smaller size garment they could wear, and the
choice of size was performed under the supervision
of the authors.
Submaximal test and bout of eccentric exercise: nine
days before the DOMS provocation, each subject per-
formed an incremental submaximal exercise test on a
motorised treadmill (EG2, Vitoria, Spain), oxygen con-
sumption was measured using a computerised meta-
bolic cart (Master Screen CPX, Erich Jaeger,
Wuerzburg, Germany). The test protocol start 3 min-
utes at 8 km/h with 3% of positive slope, and then 1
km/h speed increases every minute until to reach the
90% of the theoretical maximal heart rate. The test
was used to determinate the subject’s speed for the
DOMS provocation exercise.
The bout of eccentric exercise started with 10 min-
utes running at free speed on a treadmill (EG2, Vito-
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Table 1. Descriptive statistics, patient and test vari-
ables. MAP: Max. Aerobic Power, MAV: Max. Aerobic
Velocity, MV: Max. Velocity, AnTV: Anaerobic Thresh-
old Velocity. *: Median (Min-Max). 
Mean
Age (years) 25.0     (19-50) *
Height (cm) 177.6   (3.3)
Weight (kg) 78.2     (5.8)
BMI (Kg/m2) 24.7     (1.6)
MAP (ml) 3433    (594)
MAV (km/h) 13,9     (1,7)
VO2 mL/(kg*min) 44.0     (7.6)
MV (km/h) 13.8     (1.7)
AnTV (km/h) 11.2     (1.9)
VO2Ua (ml) 2768    (588)
Heart Rate (bpm) 163      (11.7)
Test Velocity (km/h) 10.7     (1.7)
Table 2. Treatment randomization results, according to
leg characteristics. R: Right, L: Left. 
Dominant Leg
R L Total
Compression R 6 (50%) 1 (33%) 7 (47%)
Compression L 6 (50%) 2 (67%) 8 (53%)
Total 12 3 15
Figure 1. Right tight protected and left without compression
garment. 
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ria, Spain), as a warm up, and without stop, 40 min-
utes with a 10% downhill slope, at 73% of the maxi-
mum speed reached in a submaximal test, done nine
days before. Randomly, the subjects wore the com-
pression garment on one thigh, the PT group, while
the other thigh was cut and left unprotected, the CT
group32. 
DOMS Evaluation: an initial clinical diagnosis of
DOMS, was confirmed by performing a magnetic reso-
nance imaging (MRI)42. The degree of histological in-
jury was assessed by taking a biopsy of the vastus lat-
eralis of both thighs and measuring, intracellular albu-
min, and CD3+ and MPO intra/interfibrilar infiltrates,
48 h. after the bout of eccentric exercise.
MRI: a high magnetic field system was used (Signa
1.5 T G.E. Milwaukee). The patients were placed in
the supine decubitus position and entered the explo-
ration tunnel head first. Both thighs were explored
with a coil body. The diagnosis was carried out look-
ing for alterations in the MRI signal in any muscular
group both in the flexor compartment and the extensor
and its asymmetry as regards the contralateral
homonymous muscular group. When the radiologist
read the results he did not know which thigh was pro-
tected with the tight being studied22.
Biopsies: the biopsies were obtained using a Vacora
System Biopsy pistol (Bard), with a coaxial needle of
10G X140mm. With this technique the sample is aspi-
rated and remains in the branula until it is extracted;
the sample is taken out as a whole and not fragment-
ed. Two biopsies were carried out from the middle
third of each vastus lateralis, under ultrasound control.
Previously, a cutaneous incision was performed with a
5 mm blade, the entrance was the same for both biop-
sies but the needle direction was modified6,22,42. Once
the samples were extracted, they were kept in formol,
glutaraldehyde and a third sample was cryopreserved
at -80ºC for further studying43.
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Figure 3B. Flow diagram. 
Figure 3A. Study protocol. DP: DOMS provocation. 
Figure 2. Compression garment, A: external surface, B: in-
ternal surface, C: fabric architecture. 
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Sarcolemmal disruptions evaluation: cellular mem-
brane permeability to albumin is a sign of membrane
injury37. For hystochemical procedures, all muscle
specimens were first dissected free of visible con-
nective tissue and fat and embedded in paraffin us-
ing conventional methods46. Ten-micrometre sec-
tions were cut, varying the inclination of the holder
by 5 degree increments until the minimum cross-sec-
tional area was obtained, which was defined as truly
transverse. For assessment and quantification of
muscle membrane injury we chose a method based
on light microscopy for identification of fibers that
contain albumin by immunohistochemistry. Each
sample was processed for immunohistochemical
techniques using a polyclonal rabbit anti-human anti-
body directed against albumin (Code No. A0001;
Dako Cytomation, DK-2600 Glostrup, Denmark) as a
primary antibody. This immunocomplex was detected
using a horseradish peroxidase-labeled goat anti-
rabbit secondary antibody (Code No. K4003; EnVi-
sion+System-HRP labelled polymer, Dako Co.,
Carpinteria, CA, USA). The reaction was developed
with a chromogen solution with 3.3-diaminobenzidine
(Code No. K3468; Liquid DAB+ Substrate-Chro-
mogen Solution, Dako Co., Carpinteria, CA, USA).
The analysis of intracellular albumin was performed
by two independent observers using a categorical
scale (0-3) with a light microscope (Olympus, Series
AX70TF; Olympus Optical Co., Shinjukuku, Tokyo,
Japan) coupled with an image-digitizing camera
(View Finder Lite; Version 1.0.143c; Pixera Co., Los
Gatos, CA) and a morphometry program (Scion Im-
age, Version Beta 4.0.2; Scion Co., Frederick, MD,
USA). Qualification of fiber injury was performed in a
four-category finite interval system, the extremes
representing either the absence of intracellular albu-
min (i.e., absence of sarcolemmal injury, degree 0),
or presence of intracellular albumin on the complete
cellular area (i.e., severe sarcolemmal injury, degree
3), Table 3. The two intermediate categories were
determined by degree 1 injury (i.e., mild sacolemmal
injury or presence of albumin in less than 50% of the
fiber area) and degree 2 injury (i.e., moderate sar-
colemmal injury or presence of albumin on more
than 50% of the fiber area, but not in all of it). Fiber
categories were expressed as proportion (%) of total
muscle fibers. The mean value of degree 2 and de-
gree 3 obtained by two observers was used for sta-
tistical analysis44,45.
CD3+ and MPO Immunohistochemical staining: for
assessment and quantification of CD3+ and MPO in-
tra/interfibrilar infiltrates we chose a method based on
light microscopy for identification of CD3+ and MPO
by immunohistochemistry.
For the immunohistochemical assay we used manual
immunostaining. For MPO with a polyclonal rabbit anti-
human antibody directed against MPO (Dako Ref.
IS511, 1:4 dilution, prediluted), and for CD3+ a polyclon-
al rabbit anti-human directed against CD3+ (Dako Ref.
A0452, 1:250 dilution), used as a primary antibodies. 
For MPO antigen retrieval the sections were deparaf-
finized, rehydrated in gradually decreasing concentra-
tions of ethanol, PBS (3x5’), citrate 7,3 retrieval, pres-
sure cooker, PBS (3x5’), hydrogen peroxide 10’ at
room temperature, PBS (3x5’), primary antibody 30’ at
room temperature 1:4 dilution, PBS (3x5’), secondary
antibody Envison 30’ at room temperature, PBS
(3x5’), DAB (1 drop for 1 ml dilute) 5/10 minutes at
room temperature, PBS (3x5’), Mayer haematoxylin
10’ at room temperature, water, dehydration, D.P.X.
assembly, visualization with Envison/HRP Dako
(Glostrup, Denmark).
For CD3+ antigen retrieval the sections were deparaf-
finized, rehydrated in gradually decreasing concentra-
tions of ethanol, PBS (3x5’), citrate 7,3 retrieval, pres-
sure cooker, PBS (3x5’), hydrogen peroxide 10’ at
room temperature, PBS (3x5’), primary antibody 30’ at
room temperature 1:250 dilution, PBS (3x5’), sec-
ondary antibody Envison 30’ at room temperature,
PBS (3x5’), DAB (1 drop for 1 ml dilute) 5/10 minutes
at room temperature, PBS (3x5’), Mayer haematoxylin
10’ at room temperature, water, dehydration, D.P.X.
assembly, visualization with Envison/HRP Dako
(Glostrup, Denmark).
The lymphocytic infiltrates (CD3+) and MPO were
quantified following the total number of T cells im-
munostained antibodies against CD3+, and MPO.
The total number of CD3+ cells, and the total number
of fibres were counted blindly by two observers, and
was used for statistical analysis. CD3+ cells per fibre
was calculated and compared between PT and CT40.
Number of fibres with MPO was evaluated in the
same way47,48. 
The samples were blinded to the laboratory and the
statistical analysis, coded with numbers and letters to
identify patients and treatment allocation.
Statistical Methods
Initially a descriptive analysis was performed that in-
cludes: summary tables with mean, median and stan-
dard deviation were obtained for baseline variables
(Age, Height, Weight, BMI, Max. Aerobic Power, VO2
ml/(kg* min), Max. Velocity, Anaerobic Threshold Ve-
locity, VO2Ua, Max. Aerobic Velocity, Heart Rate and
Test velocity). 
Biopsy results, total injury, intracellular albumin, CD3+,
MPO and CD3+, of each thigh (control vs. protected),
were compared, bivariate analysis was done using the
Student-Fisher t-test for paired data or the Wilcoxon
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Table 3. Fiber injury degrees description. 
Degree Description
0 Absence of intracellular albumin.
1 Presence of albumin in less than 50%
of the fiber area.
2 Presence of albumin on more than 
50% of the fiber area, but not in all of it.
3 Presence of intracellular albumin on the
complete cellular area.
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non-parametric test for non-normal distributions. The
assumption of normality was verified using the
Shapiro-Wilk test. Means of the differences with its
95% confidence intervals (IC95%) were calculated.
The results of the subjects’ thighs were graphically
represented in a scatter plot for a better visualization
of the data.
In order to analyse the variables of the biopsy adjust-
ing for patient’s characteristics and stress test gener-
alised linear models49 were used. A normal distribu-
tion was considered for Total injury, a Multinomial dis-
tribution for intracellular albumin, and a Poisson distri-
bution for CD3 and MPO. Covariates were recorded in
two categories using the median as cutting point. Co-
variates included in the final model were obtained us-
ing a backward stepwise selection method (variables
that were not statistically significant were removed
from the model).
The analysis was performed with commercially avail-
able software (SAS v9.2, SAS Institute Inc., Cary, NC,
USA), and the significant level was set to 0.05.
Results
Total injury (degrees 1, 2 and 3 together) value were
43.8 (24.93) and 71.81 (23.78) for PT and CT, respec-
tively (P = 0.0016), and the mean difference within in-
dividuals was 26.7 (CI, 12.4-41.1), Table 4. The con-
crete values for total injury for each subject, consider-
ing separately the PT and CT thighs, are shown in
Figure 4.
The values of each subject were, according to their
treatment, 75.32 % and 67.59 % higher in CT com-
pared with PT, for CD3+ and MPO infiltrates, respec-
tively. Intracellular albumin infiltrate, in absolute value,
was also 32.77% higher in CT. Total inflammatory
cells infiltrate were, thus, 72.07 % higher in CT vs. PT.
The mean value for intracellular albumin was 1.6
(0.85) and 2.38 (0.74) for PT and CT, respectively (P
= 0.0045). Within individuals, the mean difference
found was -0.85 (CI, 0.32-1.38). MPO mean value
was 1.17 (1.40) and 3.61 (4.00) for PT and CT sub-
jects, respectively (P = 0.001), being the mean differ-
ence within individuals 2.56 (CI, 0.46-4.67). Similarly,
intracellular CD3+ mean value was 0.57 (0.73) and
2.31 (3.11) for PT and CT, respectively (P = 0.0313),
and the mean difference 1.88 (CI, 0.04-3.73), Table 5.
When albumin infiltrates and injury degree were eval-
uated, CT group has more degree 1, 2 and 3 injury
than PT: 11.29%, 41.18% and 54.24% respectively;
conversely, PT has more degree 0 (no injury), than
CT, 70.13%. The total injury was higher in CT vs PT,
39.01%, Figure 5.
The variability between individuals can be explained
by some of the variables of the patient or the test.
Thus, the total injury infiltrate was greater when the
subject did the test at higher speeds. Subjects who
did the test at more than 10km/hr, had 31% more in-
jury, both in the PT and CT groups, while those who
did the test at lower intensities <1 V-%Uan, had 21%
less injury in both groups. After adjusting for these two
variables the difference between the PT and the CT
group was 31% (IC95% = 15.4 - 43.8).
The same happened with the MPO infiltrate. The sub-
jects who did the test at more than 10km/hr and those
who did it at 1V.%Uan, had 4 times more injury. After
adjusting for these variables, the CT group results
showed 3.3 (IC95% = 1.98 - 5.47) times more injury
than the PT.
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Table 4. T In: Total Injury, In 0-3: Injury degree 0-3, Dif.: Difference, SD:  Standard Deviation.
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The differences between the values of intracellular al-
bumin and CD3+ can only be explained due to the
treatment (there are no significant statistical differ-
ences in the variables of the patient or the test).
Discussion
Many studies have evaluated the use of preventative
and therapeutic measures against DOMS, but only a
single reference exists – the repeated bout effect –
with scientific evidence50. Moreover, several studies
involving different compression garments used in the
DOMS treatment27,33-36 have been described, but
none of them as a preventative measure.
Even being a common problem in sports medicine re-
search, we know the sample in our study should be
bigger, but is not easy to find athletes with good ath-
letic level wanting to participate in studies, this were
one of the reasons we decided to use the subject as
his own control. Obviously the major part of the peo-
ple was right-hand, only three subjects were left-hand
in our study, and we did not find relation between the
dominant hand and the amount of injury in our data
analysis.
The effects of the compression tights (Colibri®, Pun-
tiblond, Spain), on the biomechanics of running, high
jump and tissue oscillation during intense exercise
have been evaluated previously in different studies.
It has been observed that the use of this garment
produces a minimum decrease in hip and knee ROM
without affecting the frequency and length of the
Muscles, Ligaments and Tendons Journal 2013; 3 (4): 295-302300
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  Group Mean Median SD Min. Max. Dif. % Dif. IC 95% p-value 
Ic Alb PT 
1,6 1,5 0,85 0 3 
0,85 32,77 0,32 1,38 0,0045 
CT 2,38 2,5 0,74 1 3 
CD3 PT 
0,57 0 0,73 0 2 
1,88 75,32 0,04 3,73 0,0313 
CT 2,31 1 3,11 0 11 
MPO PT 1,17 1 1,21 0 4 2,56 67,59 0,46 4,67 0,001 
CT 3,61 2 4 0 12 
TIC PT 
1,74 1,5 1,4 0 5 
4,73 72,07 1,52 7,93 0,001 
CT 6,23 5 5,43 1 18 
&
&
Table 5. Ic Alb: Intracellular Albumin (Absolute Value), CD3: Intra/interfibrilar CD3 infiltrate, MPO: Intra/interfibrilar
Neutrophils infiltrate, TIC: Total Inflammatory cells (CD3+MPO), Dif.: Difference, SD:  Standard Deviation.
Figure 4. Scatter plots of the biopsy results for each sub-
ject. + (Control), o (Treatment). 
Figure 5. Biopsies. Ap: Albumin infil-
trate, transversal section (PT), Ac: Al-
bumin infiltrate, transversal section
(CT). Bp: Albumin infiltrate, longitudi-
nal section (PT), Bc: Albumin infil-
trate, longitudinal section (CT), Cp:
CD3 infiltrate (PT), Cc: Cd3 infiltrate
(CT). 
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stride, without affecting the efficiency of running51;
that performance in high jump is not modified41; and
the amount of the inherent muscular oscillation in
the race is smaller in the protected compression
thigh52.
The reduction in muscle oscillation is related to an im-
provement in neurotransmission and mechanical effi-
ciency at a molecule level17,20, and also, the decrease
in vibration reduces the mechanical tissue stress. And
about the influence of compression garments on me-
tabolism, although some authors have not found any
differences at an energetic level12 other groups do53.
In our study we have found a reduction in the amount
and severity of the histological muscle damage in the
PT group, and after the statistical analysis we con-
clude that this reduction is because the use of the
compression thighs. 
The reduction in the amount and severity of muscle
damage in the subjects of our study can be due to
knee and hip ROM reduction, the decrease of muscu-
lar oscillation, to the direct effect of the compression
on the muscle, or other factors (thermal effects, ve-
nous return, etc.), related to the use of compression
garments, or a combination of several of them, further
research is needed to clarify it.
DOMS is a common situation in sports practice with
several signs and symptoms, but specially, with a re-
duction in force-generating capacity37, lasting from 4
days to several weeks54,55. We know that DOMS is not
only a histological injury, but muscle function is consid-
ered to be a reliable and valid marker for the degree of
muscle damage, and, theoretically as less histological
damage, minor decrease in muscle function37. 
Strength is essential for athletic performance, strength
disturbances are a risk factor for muscle injury56,
therefore, a garment protecting against a strength re-
ducing injury, can be very useful.
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